Cognitive development in schizophrenia: Follow-back from the first episode

被引:107
作者
Bilder, RM
Reiter, G
Bates, J
Lencz, T
Szeszko, P
Goldman, RS
Robinson, D
Lieberman, JA
Kane, JM
机构
[1] Univ Calif Los Angeles, Semel Inst Neurosci, Los Angeles, CA 90095 USA
[2] Zucker Hillside Hosp, Div N Shore Long Isl Jewish Hlth Syst, Glen Oaks, NY USA
[3] Bristol Myers Squibb Co, New York, NY 10154 USA
[4] Pfizer Inc, New York, NY USA
[5] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
10.1080/13803390500360554
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Despite consensus that schizophrenia is a neurodevelopmental disorder characterized by cognitive deficits, objective data documenting the course of cognitive development remain sparse. We conducted a follow-back study of patients ascertained at the time of their initial episode of schizophrenia or schizoaffective disorder, and a group of demographically matched healthy volunteers. We obtained school records containing standardized achievement test scores from the 1st through 12th grades, and scholastic aptitude test results from the 11th and 12th grades, and examined the developmental trajectories of cognitive performance with respect to prospective examinations conducted following participants' enrollment in our study. We found significant differences in academic achievement tests as early as the first grade, with scores from participants who would later develop schizophrenia lagging behind their peers by 0.8 to 1.1 grade equivalents. This gap widened resulting in a difference between groups of 1.5 to 1.8 grade equivalents by the 12th grade. In the subset of patients for whom SAT scores were available, we found that WAIS-R Full Scale IQ was 11.5 points lower than predicted from earlier SAT scores, suggesting a substantial decline in cognitive ability accompanying the initial episode of illness. These findings suggest that schizophrenia is marked by substantial cognitive deficits in the first grade, that there may be additional subtle decline preceding the overt onset of psychotic symptoms, and that the initial episode of illness is marked by additional decline. These observations may help advance concepts of premorbid cognitive ability in the schizophrenia syndrome and constrain models of pathophysiology.
引用
收藏
页码:270 / 282
页数:13
相关论文
共 33 条
[1]  
[Anonymous], 1977, Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders
[2]  
Bilder R.M., 1985, SUBTYPING CHRONIC SC
[3]   INTELLECTUAL DEFICITS IN 1ST-EPISODE SCHIZOPHRENIA - EVIDENCE FOR PROGRESSIVE DETERIORATION [J].
BILDER, RM ;
LIPSCHUTZBROCH, L ;
REITER, G ;
GEISLER, SH ;
MAYERHOFF, DI ;
LIEBERMAN, JA .
SCHIZOPHRENIA BULLETIN, 1992, 18 (03) :437-448
[4]   NEUROPSYCHOLOGICAL DETERIORATION AND CT SCAN FINDINGS IN CHRONIC-SCHIZOPHRENIA [J].
BILDER, RM ;
DEGREEF, G ;
PANDURANGI, AK ;
RIEDER, RO ;
SACKEIM, HA ;
MUKHERJEE, S .
SCHIZOPHRENIA RESEARCH, 1988, 1 (01) :37-45
[5]   ANTERIOR HIPPOCAMPAL VOLUME REDUCTIONS PREDICT FRONTAL-LOBE DYSFUNCTION IN FIRST EPISODE SCHIZOPHRENIA [J].
BILDER, RM ;
BOGERTS, B ;
ASHTARI, M ;
WU, HW ;
ALVIR, JM ;
JODY, D ;
REITER, G ;
BELL, L ;
LIEBERMAN, JA .
SCHIZOPHRENIA RESEARCH, 1995, 17 (01) :47-58
[6]   Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates [J].
Bilder, RM ;
Goldman, RS ;
Robinson, D ;
Reiter, G ;
Bell, L ;
Bates, JA ;
Pappadopulos, E ;
Willson, DF ;
Alvir, JMJ ;
Woerner, MG ;
Geisler, S ;
Kane, JM ;
Lieberman, JA .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (04) :549-559
[7]   HIPPOCAMPUS AMYGDALA VOLUMES AND PSYCHOPATHOLOGY IN CHRONIC-SCHIZOPHRENIA [J].
BOGERTS, B ;
LIEBERMAN, JA ;
ASHTARI, M ;
BILDER, RM ;
DEGREEF, G ;
LERNER, G ;
JOHNS, C ;
MASIAR, S .
BIOLOGICAL PSYCHIATRY, 1993, 33 (04) :236-246
[8]   Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: A prospective cohort study [J].
Cannon, TD ;
Bearden, CE ;
Hollister, JM ;
Rosso, IM ;
Sanchez, LE ;
Hadley, T .
SCHIZOPHRENIA BULLETIN, 2000, 26 (02) :379-393
[9]   CAUDATE NUCLEI VOLUMES IN SCHIZOPHRENIC-PATIENTS TREATED WITH TYPICAL ANTIPSYCHOTICS OR CLOZAPINE [J].
CHAKOS, MH ;
LIEBERMAN, JA ;
ALVIR, J ;
BILDER, R ;
ASHTARI, M .
LANCET, 1995, 345 (8947) :456-457
[10]  
CHAKOS MH, 1994, AM J PSYCHIAT, V151, P1430